2017年5月25日

AWM投資公司,公司購買Ooma Inc,真皮國際公司,Kornit數字,賣……(GuruFocus)華爾街並不激動,真皮國際公司(納斯達克:科裏)的普通股發行。真皮發行了560萬股股票,價格為每股6.25美元,預計總收入約為3500萬美元。周四上午還透露,感知顧問購買近200萬真皮股票每股6.25美元。股價暴跌逾8%,因投資者可能將此舉解讀為駁斥真皮之前追求的夥伴關係。首席執行官彼得主食之前說他更喜歡為即將到來的生物製藥Corplex關鍵研究通過合作而不是股票發行,後者將稀釋股票價值。參見:獨家:真皮CEO給獨家報道在他公司的阿爾茨海默氏症的最新數據,發言人蘇珊Pietropaolo確認周四的祭,雖然臨床項目的關鍵,不是戰略偏差的症狀。“融資為真皮提供了更大的選擇和靈活性,擴大合作討論,這仍然是非常活躍,“Pietropaolo告訴Benzinga。“它為該公司提供了足夠的現金來支持多奈呱齊NDA申請關鍵研究和準備工作,如果我們決定繼續,靠自己,以及提前過去其他關鍵裏程碑在我們的業務,如潛在的批準Twirla NDA。”The funding may, in fact, lend leverage for future negotiations. "This financing puts us in an even stronger position to determine the best possible overall partnering arrangement for the company on our own terms and timing," said Pietropaolo. The Twirla NDA refers to a drug being developed by Agile Therapeutics Inc (NASDAQ: AGRX ), to which Corium is the exclusive provider. At time of publication, Corium shares were trading at $6.43, down 7.8 percent on the day. Taylor Cox contributed reporting. © 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.